Home » PROVALIS SLUMPS ON POOR FIGURES
PROVALIS SLUMPS ON POOR FIGURES
Shares
in medical diagnostics firm Provalis slumped after it reported a drop in revenue
and said it was looking to sell its medical diagnostics business. Group revenues
for the six months to December slipped to £2.6m from £6.7m in the
same period last year, while pre-tax losses increased to £2.6m compared
with £2.4m last year.
Life
Style Extra
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May